Patents Assigned to SCICANN THERAPEUTICS INC.
  • Patent number: 10966953
    Abstract: Provided herein are fixed-dose combination (FDC) compositions comprising therapeutically effective amounts of at least one cannabinoid and spilanthol whether as essentially pure isolates or synthetics or as components of essential oils or plant extracts or combinations thereof. The compositions are formulated as pharmaceutical compositions, nutraceuticals, cosmeceuticals, nutricosmetics, cosmetics, or food products. The pharmaceutical compositions are useful for the treatment of a gastro-enteric disease selected from the group consisting of irritable bowel disease, Crohn's disease, colitis, irritable bowel syndrome, and acute and chronic pancreatitis or of sepsis.
    Type: Grant
    Filed: November 28, 2019
    Date of Patent: April 6, 2021
    Assignee: SCICANN THERAPEUTICS INC.
    Inventor: Zohar Koren
  • Patent number: 10512614
    Abstract: Provided herein are fixed-dose combination (FDC) compositions comprising therapeutically effective amounts of at least one cannabinoid and spilanthol whether as essentially pure isolates or synthetics or as components of essential oils or plant extracts or combinations thereof. The compositions are formulated as pharmaceutical compositions, nutraceuticals, cosmeceuticals, nutricosmetics, cosmetics, or food products. The pharmaceutical compositions are useful for the treatment of a gastro-enteric disease selected from the group consisting of irritable bowel disease, Crohn's disease, colitis, irritable bowel syndrome, and acute and chronic pancreatitis or of sepsis.
    Type: Grant
    Filed: January 7, 2019
    Date of Patent: December 24, 2019
    Assignee: SCICANN THERAPEUTICS INC.
    Inventor: Zohar Koren
  • Patent number: 10512629
    Abstract: Provided herein are fixed-dose combination (FDC) compositions comprising therapeutically effective amounts of at least one cannabinoid and spilanthol whether as essentially pure isolates or synthetics or as components of essential oils or plant extracts or combinations thereof. The compositions are formulated as pharmaceutical compositions, nutraceuticals, cosmeceuticals, nutricosmetics, cosmetics, or food products. The pharmaceutical compositions are useful for the treatment of a gastro-enteric disease selected from the group consisting of irritable bowel disease, Crohn's disease, colitis, irritable bowel syndrome, and acute and chronic pancreatitis or of sepsis.
    Type: Grant
    Filed: July 10, 2019
    Date of Patent: December 24, 2019
    Assignee: SCICANN THERAPEUTICS INC.
    Inventor: Zohar Koren